Approaching Dexa Group’s 50-year anniversary, PT Dexa Medica was given the title of Excellent in Research and Development of Modern Medicine at the Indonesia Most Admired Companies (IMACO) Award 2019 from Warta Ekonomi. The award validates PT Dexa Medica as one of the leading national pharmaceutical companies in Indonesia, highlighting the importance of research and development in creating innovative and competitive new products for the national, regional and global market.

The award was presented directly by the former Minister of Marine Affairs and Fisheries as well as the Founder of Warta Ekonomi, Fadel Muhammad accompanied by the CEO of Warta Ekonomi, Muhammad Ihsan to the Executive Director of Dexa Laboratories of Biomolecular Sciences (DLBS) PT Dexa Medica, Dr. Raymond Tjandrawinata at Balai Kartini, Jakarta on Monday, 27 May 2019. Also present at the event was Dexa Group Head of Corporate Communications, Sonny Himawan.

Raymond said that Dexa Medica makes use of modern and sophisticated technology in producing its medicines to meet the international standards. “Modern technology is invested not only in the production process, but starting from the moment we conduct our research,” he added.

For instance, Glucient SR is one of the products created with modern technology that is top selling in the UK market. Made from a sustained release technology, Glucient SR allows people with diabetes to take the medicine only once a day.

The IMACO Award presented to Dexa Medica for its Excellent in Research and Development of Modern Medicine derives from a survey conducted by the Warta Ekonomi Research Team in 5 major cities including Jakarta, Bandung, Surabaya, Medan, Balikpapan, and Makassar. The survey captured the participation of 18,000 millennial respondents aged 20-34 years.

The large number of millennials participating in the survey relates to Dexa Group’s demographics where 80% of its employees are millennials. “The number of millennials at our company increases as we are collaborating with universities in Indonesia in order to find the best talents. Receiving this title of ‘Excellent’, Dexa hopes to continue being the pride of everyone from generation to generation, to maintain its good reputation, and to be the pioneer of research development and innovation both at the national and global level,” said Raymond. Corporate Communications coverage from Jakarta